A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines

  1. Rodríguez, J.M.
  2. Garranzo, M.
  3. Segura, J.
  4. Orgaz, B.
  5. Arroyo, R.
  6. Alba, C.
  7. Beltrán, D.
  8. Fernández, L.
Aldizkaria:
Frontiers in Microbiology

ISSN: 1664-302X

Argitalpen urtea: 2023

Alea: 14

Mota: Artikulua

DOI: 10.3389/FMICB.2023.1111652 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus